Anticancer agent 312

Overview

Anticancer agent 312 is a heterogeneous nuclear ribonucleoprotein A18 ( hnRNP A18 ) inhibitor with an IC 50 of 2.9 μM. Anticancer agent 312 binds to the RNA recognition motif of hnRNP A18 and blocks its binding to homologous RNA transcripts. Anticancer agent 312 acts as a protein synthesis inhibitor by blocking hnRNP A18 -mediated mRNA translation. Anticancer agent 312 is applicable to research on cancers such as melanoma.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > DNA/RNA Synthesis

Product Information

• Catalog No.: HY-182546
• CAS No.: 664968-32-5
• Molecular Formula: C18H14N2O3S
• Molecular Weight: 338.38
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source